Search Results - Shuliang Cao
- Showing 1 - 1 results of 1
-
1
Persistent response of furmonertinib plus anlotinib in a lung adenocarcinoma patient with an EGFR exon 20 insertion mutation: A case report by Xuesong Chen, Wangjian Zha, Mei Su, Nan Meng, Shuliang Cao, Beifang Niu, Beifang Niu, Beifang Niu, Xu Qi, Xu Qi
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book